Lmo4 synergizes with Fezf2 to promote direct in vivo reprogramming of upper layer cortical neurons and cortical glia towards deep-layer neuron identities
PLOS Biology · 08.08.2023 · 21 (8) · e3002237
DOI: 10.1371/journal.pbio.3002237 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 08.08.2023. Verfasst von Torsten Felske und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Neurons. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, AFM-Téléthon, Agence Nationale de la Recherche.
Abstract (Originalsprache)
In vivo direct neuronal reprogramming relies on the implementation of an exogenous transcriptional program allowing to achieve conversion of a particular neuronal or glial cell type towards a new identity. The transcription factor (TF) Fezf2 is known for its role in neuronal subtype specification of deep-layer (DL) subcortical projection neurons. High ectopic Fezf2 expression in mice can convert both upper-layer (UL) and striatal projection neurons into a corticofugal fate, even if at low efficiency. In this study, we show that Fezf2 synergizes with the nuclear co-adaptor Lmo4 to further enhance reprogramming of UL cortical pyramidal neurons into DL corticofugal neurons, at both embryonic and early postnatal stages. Reprogrammed neurons express DL molecular markers and project toward subcerebral targets, including thalamus, cerebral peduncle (CP), and spinal cord (SC). We also show that co-expression of Fezf2 with the reprogramming factors Neurog2 and Bcl2 in early postnatal mouse glia promotes glia-to-neuron conversion with partial hallmarks of DL neurons and with Lmo4 promoting further morphological complexity. These data support a novel role for Lmo4 in synergizing with Fezf2 during direct lineage conversion in vivo .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France.
- Research Group "Adult Neurogenesis and Cellular Reprogramming", Institute of Physiological Chemistry, University Medical Center Johannes Gutenberg University, Mainz, Germany.
- Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
- MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
- Focus Program Translational Neuroscience, Johannes Gutenberg University, Mainz, Germany.
ORCID-Profile: Michèle Studer
Förderung
- Wellcome Trust
- AFM-Téléthon
- Agence Nationale de la Recherche
- ERA-NET Neuron grant
- ERA-NET Neuron
- H2020 European Research Council
- Deutsche Forschungsgemeinschaft
- Rhineland-Palatinate Natural Products Research Centre, Johannes Gutenberg-Universität Mainz
Zitieren
APA
Felske, T., Tocco, C., Péron, S., Harb, K., Alfano, C., Galante, C., Berninger, B., & Studer, M. (2023). Lmo4 synergizes with Fezf2 to promote direct in vivo reprogramming of upper layer cortical neurons and cortical glia towards deep-layer neuron identities. PLOS Biology, 21(8), e3002237. https://doi.org/10.1371/journal.pbio.3002237
Vancouver
Felske T, Tocco C, Péron S, Harb K, Alfano C, Galante C, et al. Lmo4 synergizes with Fezf2 to promote direct in vivo reprogramming of upper layer cortical neurons and cortical glia towards deep-layer neuron identities. PLOS Biology. 2023;21(8):e3002237. doi:10.1371/journal.pbio.3002237
BibTeX
@article{Felske2023,
author = {Felske, Torsten and Tocco, Chiara and Péron, Sophie and Harb, Kawssar and Alfano, Christian and Galante, Chiara and Berninger, Benedikt and Studer, Michèle},
title = {Lmo4 synergizes with Fezf2 to promote direct in vivo reprogramming of upper layer cortical neurons and cortical glia towards deep-layer neuron identities},
journal = {PLOS Biology},
year = {2023},
volume = {21},
number = {8},
pages = {e3002237},
doi = {10.1371/journal.pbio.3002237}
}
EUVIMED